Oncolysis without viruses — inducing systemic anticancer immune responses with local therapies
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncolysis without viruses — inducing systemic anticancer immune responses with local therapies
Authors
Keywords
-
Journal
Nature Reviews Clinical Oncology
Volume 17, Issue 1, Pages 49-64
Publisher
Springer Science and Business Media LLC
Online
2019-10-08
DOI
10.1038/s41571-019-0272-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluating the Regulatory Immunomodulation Effect of Irreversible Electroporation (IRE) in Pancreatic Adenocarcinoma
- (2019) Harshul Pandit et al. ANNALS OF SURGICAL ONCOLOGY
- Local immunomodulation combined to radiofrequency ablation results in a complete cure of local and distant colorectal carcinoma
- (2019) Katia Lemdani et al. OncoImmunology
- Resolving genetic heterogeneity in cancer
- (2019) Samra Turajlic et al. NATURE REVIEWS GENETICS
- Neoantigen-directed immune escape in lung cancer evolution
- (2019) Rachel Rosenthal et al. NATURE
- Tissue-Resident T Cells and Other Resident Leukocytes
- (2019) David Masopust et al. Annual Review of Immunology
- Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
- (2019) Linda Hammerich et al. NATURE MEDICINE
- Extracorporeal Photochemotherapy Drives Monocyte-to-Dendritic Cell Maturation to Induce Anticancer Immunity
- (2018) Alessandra Ventura et al. CANCER RESEARCH
- Y-90 Radioembolization Combined with a PD-1 Inhibitor for Advanced Hepatocellular Carcinoma
- (2018) Eric Wehrenberg-Klee et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Oncolytic viruses and immunity
- (2018) Shyambabu Chaurasiya et al. CURRENT OPINION IN IMMUNOLOGY
- Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma
- (2018) Valerie Chew et al. GUT
- Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma
- (2018) Jason Chesney et al. JOURNAL OF CLINICAL ONCOLOGY
- Nanofluidic drug-eluting seed for sustained intratumoral immunotherapy in triple negative breast cancer
- (2018) Corrine Ying Xuan Chua et al. JOURNAL OF CONTROLLED RELEASE
- Sustained release of anti-PD-1 peptide for perdurable immunotherapy together with photothermal ablation against primary and distant tumors
- (2018) Lihua Luo et al. JOURNAL OF CONTROLLED RELEASE
- Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity
- (2018) Victor H. Engelhard et al. JOURNAL OF IMMUNOLOGY
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
- (2018) Franck Pagès et al. LANCET
- Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
- (2018) Mark A. Socinski et al. NEW ENGLAND JOURNAL OF MEDICINE
- The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies
- (2018) Laurence Zitvogel et al. SCIENCE
- Eradication of spontaneous malignancy by local immunotherapy
- (2018) Idit Sagiv-Barfi et al. Science Translational Medicine
- Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect
- (2018) María E. Rodríguez-Ruiz et al. TRENDS IN IMMUNOLOGY
- Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies
- (2018) Shashi Gujar et al. TRENDS IN IMMUNOLOGY
- Enhanced antitumor efficacy through microwave ablation in combination with immune checkpoints blockade in breast cancer: A pre-clinical study in a murine model
- (2018) J. Zhu et al. Diagnostic and Interventional Imaging
- Lighting a Fire in the Tumor Microenvironment Using Oncolytic Immunotherapy
- (2018) Carole Achard et al. EBioMedicine
- Immunotherapy Plus Cryotherapy: Potential Augmented Abscopal Effect for Advanced Cancers
- (2018) Joe Abdo et al. Frontiers in Oncology
- Combined local immunostimulatory radioisotope therapy and systemic immune checkpoint blockade imparts potent antitumour responses
- (2018) Yu Chao et al. Nature Biomedical Engineering
- Safety and Short-Term Efficacy of Irreversible Electroporation and Allogenic Natural Killer Cell Immunotherapy Combination in the Treatment of Patients with Unresectable Primary Liver Cancer
- (2018) Yumei Yang et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Combined Effects of Yttrium-90 Transarterial Radioembolization around Immunotherapy for Hepatic Metastases from Uveal Melanoma: A Preliminary Retrospective Case Series
- (2018) Jiahe Zheng et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Successful treatment with intralesional talimogene laherparepvec in two patients with immune checkpoint inhibitors refractory advanced melanoma
- (2018) Teofila Seremet et al. MELANOMA RESEARCH
- The anticancer peptide RT53 induces immunogenic cell death
- (2018) Ewa Pasquereau-Kotula et al. PLoS One
- The hallmarks of successful anticancer immunotherapy
- (2018) Lorenzo Galluzzi et al. Science Translational Medicine
- In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma
- (2018) Matthew J. Frank et al. Cancer Discovery
- Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)
- (2018) A Marabelle et al. ANNALS OF ONCOLOGY
- Evolution of Metastases in Space and Time under Immune Selection
- (2018) Mihaela Angelova et al. CELL
- Tremelimumab in combination with microwave ablation in patients with refractory biliary tract cancer
- (2018) Changqing Xie et al. HEPATOLOGY
- Early Immunologic Response of Irreversible Electroporation versus Cryoablation in a Rodent Model of Pancreatic Cancer
- (2018) Sarah B. White et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Radiotherapy induces responses of lung cancer to CTLA-4 blockade
- (2018) Silvia C. Formenti et al. NATURE MEDICINE
- In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
- (2018) Qian Chen et al. Nature Nanotechnology
- Trial watch: The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors
- (2018) Jun Tang et al. NATURE REVIEWS DRUG DISCOVERY
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Electrochemotherapy with cisplatin increases survival and induces immunogenic responses in murine models of lung cancer and colorectal cancer
- (2018) Liam Friel Tremble et al. CANCER LETTERS
- Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance
- (2017) Norma Bloy et al. IMMUNOLOGICAL REVIEWS
- History of bystander effects research 1905-present; what is in a name?
- (2017) Carmel Mothersill et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- The immune contexture in cancer prognosis and treatment
- (2017) Wolf H. Fridman et al. Nature Reviews Clinical Oncology
- Radiotherapy and immunotherapy: a beneficial liaison?
- (2017) Ralph R. Weichselbaum et al. Nature Reviews Clinical Oncology
- A practical guide to the handling and administration of talimogene laherparepvec in Europe
- (2017) Kevin Harrington et al. OncoTargets and Therapy
- DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
- (2017) Claire Vanpouille-Box et al. Nature Communications
- Photodynamic-Immune Checkpoint Therapy Eradicates Local and Distant Tumors by CD8 + T Cells
- (2017) Jan Willem Kleinovink et al. Cancer Immunology Research
- Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model
- (2017) Janne Nestvold et al. OncoImmunology
- Immuno-thermal ablations – boosting the anticancer immune response
- (2017) Ryan Slovak et al. Journal for ImmunoTherapy of Cancer
- Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial
- (2016) Robert H. I. Andtbacka et al. ANNALS OF SURGICAL ONCOLOGY
- Calreticulin Expression in Human Non–Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis
- (2016) Jitka Fucikova et al. CANCER RESEARCH
- Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells
- (2016) Saïda Dadi et al. CELL
- The Basis of Oncoimmunology
- (2016) A. Karolina Palucka et al. CELL
- The oncolytic compound LTX-401 targets the Golgi apparatus
- (2016) Heng Zhou et al. CELL DEATH AND DIFFERENTIATION
- The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade
- (2016) T Yamazaki et al. CELL DEATH AND DIFFERENTIATION
- PD-1 Blockade Boosts Radiofrequency Ablation-Elicited Adaptive Immune Responses against Tumor
- (2016) L. Shi et al. CLINICAL CANCER RESEARCH
- Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
- (2016) Christina Pfirschke et al. IMMUNITY
- Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant Melanoma
- (2016) S. Theurich et al. Cancer Immunology Research
- Challenges of phase 1 clinical trials evaluating immune checkpoint-targeted antibodies
- (2015) S. Postel-Vinay et al. ANNALS OF ONCOLOGY
- Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
- (2015) Lorenzo Galluzzi et al. CANCER CELL
- Talimogene Laherparepvec: First Global Approval
- (2015) Sarah L. Greig DRUGS
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Transarterial approaches to primary and secondary hepatic malignancies
- (2015) Ali Habib et al. Nature Reviews Clinical Oncology
- Oncolytic viruses: a new class of immunotherapy drugs
- (2015) Howard L. Kaufman et al. NATURE REVIEWS DRUG DISCOVERY
- STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade
- (2015) Juan Fu et al. Science Translational Medicine
- Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy
- (2015) Nicola Mozzillo et al. OncoImmunology
- Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunity
- (2014) Zoya Alteber et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cryotherapy with Concurrent CpG Oligonucleotide Treatment Controls Local Tumor Recurrence and Modulates HER2/neu Immunity
- (2014) J. J. Veenstra et al. CANCER RESEARCH
- Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment
- (2014) Yonit Lavin et al. CELL
- Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulation
- (2014) Barbara Behm et al. GUT
- Heat Shock Protein 70, Released from Heat-Stressed Tumor Cells, Initiates Antitumor Immunity by Inducing Tumor Cell Chemokine Production and Activating Dendritic Cells via TLR4 Pathway
- (2014) T. Chen et al. JOURNAL OF IMMUNOLOGY
- Radiotherapy for renal-cell carcinoma
- (2014) Gert De Meerleer et al. LANCET ONCOLOGY
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
- (2014) D. Zamarin et al. Science Translational Medicine
- Molecular mechanisms of ATP secretion during immunogenic cell death
- (2013) I Martins et al. CELL DEATH AND DIFFERENTIATION
- Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
- (2013) Aurélien Marabelle et al. JOURNAL OF CLINICAL INVESTIGATION
- Bleomycin Exerts Ambivalent Antitumor Immune Effect by Triggering Both Immunogenic Cell Death and Proliferation of Regulatory T Cells
- (2013) Hélène Bugaut et al. PLoS One
- A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
- (2012) Abhishek D Garg et al. EMBO JOURNAL
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- (2012) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti-CTLA-4 Therapy
- (2011) R. Waitz et al. CANCER RESEARCH
- Notch2 Receptor Signaling Controls Functional Differentiation of Dendritic Cells in the Spleen and Intestine
- (2011) Kanako L. Lewis et al. IMMUNITY
- Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
- (2011) M. Michaud et al. SCIENCE
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Systemic inflammatory response and downmodulation of peripheral CD25+Foxp3+ T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer
- (2009) Anna Maria Fietta et al. HUMAN IMMUNOLOGY
- Cryoablation induces greater inflammatory and coagulative responses than radiofrequency ablation or laser induced thermotherapy in a rat liver model
- (2009) Maarten C. Jansen et al. SURGERY
- Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity
- (2008) Dina Preise et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cryo-immunology: A review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses
- (2008) Michael S. Sabel CRYOBIOLOGY
- Shortening the Timeline of Pediatric Phase I Trials: The Rolling Six Design
- (2008) Jeffrey M. Skolnik et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search